News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Red...

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Reductio

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine)...

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tabl

Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 2...

Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 20

Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, us...

Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to

Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference

Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference

New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments

New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal...

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Gui...

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance

Top Stories

Read the latest Teva news

“This ‘invisible pandemic’ is one of the biggest global health challenges”

“This ‘invisible pandemic’ is one of the biggest global health challenges”

Introducing Teva USA’s HBA Rising Stars & Luminary

Introducing Teva USA’s HBA Rising Stars & Luminary

The secret to achieving our new environmental targets? Our people

The secret to achieving our new environmental targets? Our people

The hidden impact of migraine on millions of women

The hidden impact of migraine on millions of women

"Bringing more women and more diversity into our leadership makes us stronger."

"Bringing more women and more diversity into our leadership makes us stronger."

Meet the Expert: Professor Ruth Arnon

Meet the Expert: Professor Ruth Arnon

Improving access to medicines for 4000 children with cancer in Malawi

Improving access to medicines for 4000 children with cancer in Malawi

How do I…put patient safety first?

How do I…put patient safety first?

Media Resources

Intended for use by media professionals; may be downloaded for non-commercial use 

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us